A Double-Blind, Multicenter Study to Assess the LDL-C Lowering of Combination Tablets Ezetimibe/Simvastatin (10mg/20mg) and Ezetimibe/Simvastatin (10mg/40mg) Compared to Atorvastatin 20 mg in Patients With Type II Diabetes.
Latest Information Update: 19 Aug 2024
At a glance
- Drugs Atorvastatin (Primary) ; Ezetimibe/simvastatin (Primary)
- Indications Hypercholesterolaemia; Lipid metabolism disorders
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme; Merck/Schering-Plough Pharmaceuticals; Organon
- 30 Aug 2005 New trial record.